Ocean Biomedical Announces Initiation of Coverage by Taglich Brothers with a Share Price T - Benzinga
| OCEAW Stock | 0.03 0.0004 1.38% |
Slightly above 61% of Ocean Biomedical's investor base is looking to short. The analysis of the overall investor sentiment regarding Ocean Biomedical suggests that many traders are alarmed. Ocean Biomedical's investing sentiment can be driven by a variety of factors including economic data, Ocean Biomedical's earnings reports, geopolitical events, and overall market trends.
Ocean |
Ocean Biomedical Announces Initiation of Coverage by Taglich Brothers with a Share Price T Benzinga
Read at news.google.com
 |
Ocean Biomedical Fundamental Analysis
We analyze Ocean Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocean Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocean Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Ocean Biomedical is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Ocean Biomedical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ocean Biomedical stock to make a market-neutral strategy. Peer analysis of Ocean Biomedical could also be used in its relative valuation, which is a method of valuing Ocean Biomedical by comparing valuation metrics with similar companies.
Peers
Ocean Biomedical Related Equities
| VLGEA | Village Super | 2.00 | ||||
| INGR | Ingredion Incorporated | 0.92 | ||||
| ACI | Albertsons Companies | 0.82 | ||||
| LWAY | Lifeway Foods | 0.35 | ||||
| MITN | AG Mortgage | 0.24 | ||||
| GGDVF | Guangdong Investment | 0.00 | ||||
| TBBB | BBB Foods | 0.30 | ||||
| VRTS | Virtus Investment | 0.76 |
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.